ATE306480T1 - Trizyclische alkylhydroxamate, ihre herstellung und ihre verwendung als inhibitoren der zellproliferation - Google Patents
Trizyclische alkylhydroxamate, ihre herstellung und ihre verwendung als inhibitoren der zellproliferationInfo
- Publication number
- ATE306480T1 ATE306480T1 AT02724292T AT02724292T ATE306480T1 AT E306480 T1 ATE306480 T1 AT E306480T1 AT 02724292 T AT02724292 T AT 02724292T AT 02724292 T AT02724292 T AT 02724292T AT E306480 T1 ATE306480 T1 AT E306480T1
- Authority
- AT
- Austria
- Prior art keywords
- trizyclic
- preparation
- cell proliferation
- proliferation inhibitors
- alkyl hydroxamates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01109428 | 2001-04-23 | ||
PCT/EP2002/004349 WO2002085883A1 (en) | 2001-04-23 | 2002-04-19 | Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE306480T1 true ATE306480T1 (de) | 2005-10-15 |
Family
ID=8177162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02724292T ATE306480T1 (de) | 2001-04-23 | 2002-04-19 | Trizyclische alkylhydroxamate, ihre herstellung und ihre verwendung als inhibitoren der zellproliferation |
Country Status (16)
Country | Link |
---|---|
US (1) | US6512123B2 (de) |
EP (1) | EP1385837B1 (de) |
JP (1) | JP4142453B2 (de) |
KR (1) | KR100591501B1 (de) |
CN (1) | CN1310904C (de) |
AR (1) | AR035455A1 (de) |
AT (1) | ATE306480T1 (de) |
AU (1) | AU2002254991B2 (de) |
BR (1) | BR0209064A (de) |
CA (1) | CA2442994A1 (de) |
CR (1) | CR9430A (de) |
DE (1) | DE60206616T2 (de) |
ES (1) | ES2249572T3 (de) |
MX (1) | MXPA03009132A (de) |
WO (1) | WO2002085883A1 (de) |
ZA (1) | ZA200307793B (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2004067480A2 (en) * | 2003-01-25 | 2004-08-12 | Oxford Glycosciences (Uk) Ltd | Substituted phenylurea derivatives as hdac inhibitors |
WO2004082638A2 (en) | 2003-03-17 | 2004-09-30 | Syrrx, Inc. | Histone deacetylase inhibitors |
EP2238982B8 (de) | 2003-06-27 | 2013-01-16 | Astellas Pharma Inc. | Therapiemittel für Weichgewebesarkom |
WO2005058298A2 (en) * | 2003-12-10 | 2005-06-30 | Wisconsin Alumni Research Foundation | Fk228 analogs and their use as hdac-inhibitors |
US20050159470A1 (en) * | 2003-12-19 | 2005-07-21 | Syrrx, Inc. | Histone deacetylase inhibitors |
US20050137234A1 (en) * | 2003-12-19 | 2005-06-23 | Syrrx, Inc. | Histone deacetylase inhibitors |
US20060128660A1 (en) * | 2004-12-10 | 2006-06-15 | Wisconsin Alumni Research Foundation | FK228 analogs and methods of making and using the same |
US7642275B2 (en) * | 2004-12-16 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
IT1362675B (it) * | 2005-03-15 | 2009-06-25 | Menarini Internat Operations Luxembourg Sa | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche |
AU2006226861B2 (en) | 2005-03-22 | 2012-08-16 | Dana-Farber Cancer Institute, Inc. | Treatment of protein degradation disorders |
WO2006122319A2 (en) * | 2005-05-11 | 2006-11-16 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
ES2540204T3 (es) * | 2005-05-13 | 2015-07-09 | Topotarget Uk Limited | Formulaciones farmacéuticas de inhibidores de la HDAC |
ZA200800901B (en) | 2005-07-14 | 2010-05-26 | Takeda San Diego Inc | Histone deacetylase inhibitors |
WO2007077111A1 (en) * | 2005-12-30 | 2007-07-12 | F. Hoffmann-La Roche Ag | Compounds and methods for carbazole synthesis |
JP2009525955A (ja) * | 2006-01-13 | 2009-07-16 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
ES2481413T3 (es) | 2006-02-14 | 2014-07-30 | The President And Fellows Of Harvard College | Inhibidores de histona desacetilasa |
CA2642273C (en) | 2006-02-14 | 2016-09-20 | President And Fellows Of Harvard College | Bifunctional histone deacetylase inhibitors |
JP5497431B2 (ja) * | 2006-05-03 | 2014-05-21 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ヒストンデアセチラーゼおよびチューブリンデアセチラーゼ阻害剤 |
ES2288803B1 (es) * | 2006-07-07 | 2008-12-16 | Universidad De Granada | Derivados de benzo(d)isotiazoles como inhibidores de las histonas desacetilasas. |
CL2007003108A1 (es) * | 2006-10-28 | 2008-07-18 | Methylgene Inc Envivo Pharmace | Compuestos derivados de n-hidroxiamida sustituida con heterociclos, inhibidores de histona desacetilasa; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad del grupo que consiste en enfermedad de huntington, |
AU2013205135B2 (en) * | 2006-10-28 | 2015-11-05 | Forum Pharmaceuticals Inc. | Inhibitors of histone deacetylase |
JP5665740B2 (ja) | 2008-07-23 | 2015-02-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | デアセチラーゼ阻害剤およびその使用 |
JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5阻害剤 |
WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
US10106488B2 (en) * | 2014-01-28 | 2018-10-23 | Nippon Shokubai Co., Ltd. | Hydrogenation reaction method |
WO2017030892A1 (en) | 2015-08-14 | 2017-02-23 | Reaction Biology Corp. | Histone deacetylase inhibitors and methods for use thereof |
WO2023020416A1 (zh) * | 2021-08-16 | 2023-02-23 | 勤浩医药(苏州)有限公司 | 三环化合物、包含其的药物组合物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2208893A1 (de) | 1972-02-25 | 1973-08-30 | Boehringer Mannheim Gmbh | Tricyclische alpha-oxy-carbonsaeurederivate und verfahren zur herstellung derselben |
US5369108A (en) * | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
ZA938897B (en) * | 1992-12-01 | 1994-08-01 | Smithkline Beecham Corp | Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds |
WO1998009934A1 (en) * | 1996-09-04 | 1998-03-12 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
AU7320100A (en) * | 1999-09-24 | 2001-04-24 | Ono Pharmaceutical Co. Ltd. | Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
-
2002
- 2002-04-08 AR ARP020101282A patent/AR035455A1/es not_active Application Discontinuation
- 2002-04-19 BR BR0209064-3A patent/BR0209064A/pt not_active IP Right Cessation
- 2002-04-19 MX MXPA03009132A patent/MXPA03009132A/es active IP Right Grant
- 2002-04-19 DE DE60206616T patent/DE60206616T2/de not_active Expired - Fee Related
- 2002-04-19 ES ES02724292T patent/ES2249572T3/es not_active Expired - Lifetime
- 2002-04-19 JP JP2002583410A patent/JP4142453B2/ja not_active Expired - Fee Related
- 2002-04-19 CA CA002442994A patent/CA2442994A1/en not_active Abandoned
- 2002-04-19 EP EP02724292A patent/EP1385837B1/de not_active Expired - Lifetime
- 2002-04-19 WO PCT/EP2002/004349 patent/WO2002085883A1/en active IP Right Grant
- 2002-04-19 AT AT02724292T patent/ATE306480T1/de not_active IP Right Cessation
- 2002-04-19 KR KR1020037013744A patent/KR100591501B1/ko not_active IP Right Cessation
- 2002-04-19 AU AU2002254991A patent/AU2002254991B2/en not_active Ceased
- 2002-04-19 CN CNB028086546A patent/CN1310904C/zh not_active Expired - Fee Related
- 2002-04-22 US US10/127,100 patent/US6512123B2/en not_active Expired - Fee Related
-
2003
- 2003-10-06 ZA ZA200307793A patent/ZA200307793B/en unknown
-
2007
- 2007-10-11 CR CR9430A patent/CR9430A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1507441A (zh) | 2004-06-23 |
BR0209064A (pt) | 2004-08-10 |
CA2442994A1 (en) | 2002-10-31 |
AU2002254991B2 (en) | 2007-07-19 |
WO2002085883A1 (en) | 2002-10-31 |
ZA200307793B (en) | 2005-01-06 |
MXPA03009132A (es) | 2004-02-12 |
KR100591501B1 (ko) | 2006-06-19 |
EP1385837A1 (de) | 2004-02-04 |
JP4142453B2 (ja) | 2008-09-03 |
ES2249572T3 (es) | 2006-04-01 |
AR035455A1 (es) | 2004-05-26 |
EP1385837B1 (de) | 2005-10-12 |
US6512123B2 (en) | 2003-01-28 |
CN1310904C (zh) | 2007-04-18 |
DE60206616D1 (de) | 2006-02-23 |
CR9430A (es) | 2008-04-25 |
JP2005503341A (ja) | 2005-02-03 |
DE60206616T2 (de) | 2006-07-13 |
KR20030090771A (ko) | 2003-11-28 |
US20020183513A1 (en) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE306480T1 (de) | Trizyclische alkylhydroxamate, ihre herstellung und ihre verwendung als inhibitoren der zellproliferation | |
DE60208661D1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
FR12C0019I2 (fr) | O-cyclopropyle-carboxanilides et leur utilisation comme fongicides | |
ATE339419T1 (de) | Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren | |
DE60317093D1 (de) | Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide | |
ATE424202T1 (de) | Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung | |
DE60118975D1 (de) | Tetrahydropyridinderivate, deren herstellung und deren verwendung als inhibitoren der zellproliferation | |
DE69926800D1 (de) | Benzoheterozyklen und ihre verwendung als mek inhibitoren | |
DE60036803D1 (de) | Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel | |
DE50207849D1 (de) | Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung | |
DE60123210D1 (de) | Picolinsäure-derivate und ihre verwendung als fungizide | |
ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
DE60200427D1 (de) | Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung | |
ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
DE602004010426D1 (de) | Mikrobizide zusammensetzungen und ihre verwendung | |
DE60321958D1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
DE50313157D1 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
DE50206094D1 (de) | Substituierte isoindole und ihre verwendung | |
ATE362469T1 (de) | 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren | |
DE60318317D1 (de) | Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren | |
DE60230162D1 (de) | Polymerisate und ihre verwendung | |
ATE396994T1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
DE50008549D1 (de) | Triazolotriazinone und ihre verwendung | |
ATE353083T1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1385837 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |